|
Originally published In Press as doi:10.1074/jbc.M807185200 on November 11, 2008
J. Biol. Chem., Vol. 284, Issue 2, 872-883, January 9, 2009
p53 Family Members Regulate the Expression of the Apolipoprotein D Gene*
Yasushi Sasaki ,
Hideaki Negishi ,
Ryota Koyama ,
Naoki Anbo ,
Kanae Ohori ,
Masashi Idogawa ,
Hiroaki Mita ,
Minoru Toyota ,
Kohzoh Imai ,
Yasuhisa Shinomura , and
Takashi Tokino 1
From the
Department of Molecular Biology, Cancer Research Institute and First Department of Internal Medicine, Sapporo Medical University, S-1, W-17, Chuo-ku, Sapporo, 060-8556 Japan
p73 and p63 are members of the p53 gene family that play an important role in development and homeostasis, mainly by regulating transcription of a variety of genes. We report here that apolipoprotein D (apoD), a member of the lipocalin superfamily of lipid transport proteins, is a direct transcriptional target of the p53 family member genes. We found that the expression of apoD was specifically up-regulated by either TAp73 or TAp63 but not significantly by p53. In addition, apoD transcription is activated in response to cisplatin in a manner dependent on endogenous p73. By using small interference RNA designed to target p73, we demonstrated that silencing endogenous p73 abolishes induction of apoD transcription following cisplatin treatment. We also identified a p73/p63-binding site in the promoter of the apoD gene that is responsive to the p53 family members. The ectopic expression of TAp73 as well as the addition of recombinant human apoD to culture medium induced the osteoblastic differentiation of the human osteosarcoma cell line Saos-2, as assessed by alkaline phosphatase activity. Importantly, apoD knockdown abrogated p73-mediated alkaline phosphatase induction. Moreover, TAp73-mediated apoD expression was able to induce morphological differentiation, as well as expression of neuronal markers, in the human neuroblastoma cell line SH-SY5Y. These results suggest that apoD induction may mediate the activity of p73 in normal development.
Received for publication, September 16, 2008
, and in revised form, November 10, 2008.
* This work was supported in part by grants-in-aid for cancer research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Primary array data sets can be accessed through the NCBI Gene Expression Omnibus (GEO) under GEO accession number GSE13504
[NCBI GEO]
.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. 1 and 2.
1 To whom correspondence should be addressed: Dept. of Molecular Biology, Cancer Research Institute, Sapporo Medical University, S-1, W-17, Chuo-ku, Sapporo, 060-8556 Japan. Tel.: 81-11-611-2111 (ext. 2410); Fax: 81-11-618-3313; E-mail: tokino{at}sapmed.ac.jp.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|